New Molecules and Cures for Tooth Agenesis
牙齿发育不全的新分子和治疗方法
基本信息
- 批准号:9393594
- 负责人:
- 金额:$ 36.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-01 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAffectAgonistApplications GrantsBasic ScienceBindingBiological AssayCleft PalateComplexDataDefectDentalDentitionDevelopmentDiseaseElementsEmotionalEpithelialEpitheliumEquilibriumEstheticsEventFamilyFemaleFutureGene ExpressionGene Expression ProfilingGene Expression RegulationGenesGeneticGenetic ModelsGenetic studyGoalsHumanHuman GeneticsIn VitroInborn Genetic DiseasesInheritedInjection of therapeutic agentKnowledgeMediatingMesenchymalMesenchymeMicroarray AnalysisMolecularMorphogenesisMothersMusMutant Strains MiceMutationNatureOdontogenesisOrganPathway interactionsPatientsPatternPhasePhenotypePlayPopulationProcessPromoter RegionsProteinsReplacement TherapyReporter GenesReportingResearchRoleSeriesSignal PathwaySignal TransductionSignaling MoleculeTailTestingTherapeuticTimeTooth structureTranslatingTranslationsVariantVeinsWNT Signaling PathwayWNT10A genebaseclinically relevantdesignexperimental studyfunctional restorationgenetic analysisimprovedin vivoinhibitor/antagonistinsightmutantnovelnovel therapeutic interventionnovel therapeuticspregnantpromoterpuprestorationsmall moleculesynergismtargeted treatmenttranscription factortranscriptome sequencingtranslational approachtranslational study
项目摘要
PROJECT SUMMARY
The development of dentition is a highly complex process that involves a series of reciprocal epithelial-
mesenchyme interactions that are regulated by five conserved signaling pathways, namely Bmp, Fgf, Wnt, Eda
and Shh. That such a precise process is often perturbed is not surprising. Indeed, tooth agenesis is one of the
most commonly inherited human disorders that affects up to 10% of the population and imposes significant
burdens on patients and their families. Mutations in PAX9, a paired-domain transcription factor that is
specifically expressed in dental mesenchyme, cause human tooth agenesis. The deletion of Pax9 in mice leads
to tooth arrest at the bud stage, thus underscoring its key inductive role within dental mesenchyme. Better
understanding the molecular actions of Pax9 in dental mesenchyme during the induction phase of tooth
morphogenesis offers hope for the development of tangible therapies that can benefit patients with tooth
agenesis. Our microarray analyses of Pax9-/- tooth organs show that Wnt signaling genes are most markedly
altered along with the Bmps, Fgfs, Shh and Eda-related genes. The results of our human genetic analyses and
data from other groups confirm that mutations in WNT10A are responsible for the majority of cases of human
tooth agenesis. Significantly, our preliminary experiments suggest that Wnt agonists, when administered to
pregnant Pax9+/- mothers, are able to rescue the mutant phenotype of cleft palate and tooth arrest. Despite
these advances there is little understood about the precise molecular relationship of Pax9 with the Wnt
signaling pathway in dental mesenchyme and how such basic science knowledge can be translated into new
advances for the treatment of human tooth agenesis. Taken together, our data provide the framework for
studies that will systematically test the hypothesis that Pax9 is a key modulator of signaling events in dental
mesenchyme during early tooth morphogenesis through its regulation of genes in the Wnt pathway. The
restoration of Wnt signaling in Pax9 and Wnt10a mutant dental mesenchyme is hence likely to normalize tooth
morphogenesis. Aim 1 studies will use multipronged approaches to provide new data on the molecular
relationship of Pax9 with genes that regulate Wnt signaling activities in dental mesenchyme during early
morphogenesis since this relationship is not as well studied as that with the Bmp and Fgf pathways. Aim 2 will
test how human tooth agenesis-causing mutations in Pax9 and Wnt10A affect the functional relationship of
these genes to result in an arrest in tooth development. Aim 3 will confirm the upstream relationship of Pax9
by assessing whether novel Wnt-based therapeutics when administered in-vivo, can correct the Pax9-/- tooth
agenesis phenotype through a restoration of Wnt function. Data from these basic science and translational
studies will advance our understanding about the signaling molecules in dental mesenchyme and will provide
the framework for developing and testing non-invasive therapies to restore tooth development in humans
affected by non-syndromic tooth agenesis, an important problem of high clinical relevance and for which there
are no cures.
项目概要
牙列的发育是一个高度复杂的过程,涉及一系列相互的上皮细胞
间充质相互作用受五个保守信号通路调节,即 Bmp、Fgf、Wnt、Eda
和嘘。如此精确的过程经常受到干扰并不奇怪。事实上,牙齿发育不全是其中之一
最常见的遗传性人类疾病,影响高达 10% 的人口,并造成严重影响
给患者及其家属带来负担。 PAX9 的突变,PAX9 是一种配对结构域转录因子
特异表达于牙齿间充质,导致人类牙齿发育不全。小鼠体内 Pax9 的缺失导致
使牙齿在芽期停止,从而强调其在牙齿间充质中的关键诱导作用。更好的
了解牙齿诱导阶段 Pax9 在牙齿间充质中的分子作用
形态发生为开发有形疗法带来希望,使牙齿患者受益
发育不全。我们对 Pax9-/- 牙齿器官的微阵列分析表明,Wnt 信号基因最显着
与 Bmps、Fgfs、Shh 和 Eda 相关基因一起改变。我们的人类基因分析结果和
其他小组的数据证实,WNT10A 突变是导致大多数人类病例的原因。
牙齿发育不全。值得注意的是,我们的初步实验表明,当给予 Wnt 激动剂时
怀孕的 Pax9+/- 母亲,能够挽救腭裂和牙齿停滞的突变表型。尽管
这些进展对于 Pax9 与 Wnt 的精确分子关系知之甚少
牙齿间充质中的信号通路以及如何将这些基础科学知识转化为新的知识
治疗人类牙齿发育不全的进展。总而言之,我们的数据提供了框架
研究将系统地检验 Pax9 是牙科信号事件关键调节剂的假设
间充质在早期牙齿形态发生过程中通过调节 Wnt 通路中的基因来发挥作用。这
Pax9 和 Wnt10a 突变体牙齿间充质中 Wnt 信号的恢复因此可能使牙齿正常化
形态发生。目标 1 研究将使用多管齐下的方法来提供分子生物学的新数据
Pax9与早期牙间充质Wnt信号活性调节基因的关系
形态发生,因为这种关系不像 Bmp 和 Fgf 途径那样得到充分研究。目标2将
测试引起人类牙齿发育不全的 Pax9 和 Wnt10A 突变如何影响功能关系
这些基因导致牙齿发育停滞。目标3将确认Pax9的上游关系
通过评估基于 Wnt 的新型疗法在体内施用时是否可以矫正 Pax9-/- 牙齿
通过恢复 Wnt 功能来实现发育不全表型。来自这些基础科学和转化的数据
研究将增进我们对牙齿间充质信号分子的理解,并将提供
开发和测试恢复人类牙齿发育的非侵入性疗法的框架
受非综合征性牙齿发育不全的影响,这是一个具有高度临床相关性的重要问题,为此有
没有治愈方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rena N. D'Souza其他文献
Gene Expression Patterns of Murine Dentin Matrix Protein 1 (Dmp1) and Dentin Sialophosphoprotein (DSPP) Suggest Distinct Developmental Functions In Vivo
小鼠牙本质基质蛋白 1 (Dmp1) 和牙本质唾液磷蛋白 (DSPP) 的基因表达模式表明不同的体内发育功能
- DOI:
10.1359/jbmr.1997.12.12.2040 - 发表时间:
1997-12-01 - 期刊:
- 影响因子:6.2
- 作者:
Rena N. D'Souza;A. Cavender;G. Sunavala;J. Alvarez;Toshio Ohshima;Ashok B. Kulkarni;Mary Macdougall - 通讯作者:
Mary Macdougall
Bone Morphogenetic Protein-7 (Osteogenic Protein-1, OP-1) and Tooth Development
骨形态发生蛋白 7(成骨蛋白 1、OP-1)与牙齿发育
- DOI:
10.1177/00220345980770040701 - 发表时间:
1998-04-01 - 期刊:
- 影响因子:7.6
- 作者:
M. N. Helder;H. Karg;T. Bervoets;Slobodan Vukicevic;E. H. Burger;Rena N. D'Souza;J. Wöltgens;G. Karsenty;A. Bronckers - 通讯作者:
A. Bronckers
TEGDMA Reduces Mineralization in Dental Pulp Cells
TEGDMA 减少牙髓细胞的矿化
- DOI:
10.1177/0022034510384618 - 发表时间:
2011-02-01 - 期刊:
- 影响因子:7.6
- 作者:
K. Galler;K. Galler;H. Schweikl;K. Hiller;A. Cavender;C. Bolay;Rena N. D'Souza;Gottfried Schmalz - 通讯作者:
Gottfried Schmalz
Ex Vivo Modeling of Multidomain Peptide Hydrogels with Intact Dental Pulp
完整牙髓多域肽水凝胶的离体建模
- DOI:
10.1177/0022034515600380 - 发表时间:
2015-08-18 - 期刊:
- 影响因子:7.6
- 作者:
Am;a N. Moore;a;S. C. Perez;J. Hartgerink;Rena N. D'Souza;John S. Colombo - 通讯作者:
John S. Colombo
OP‐1 (BMP‐7) Affects mRNA Expression of Type I, II, X Collagen, and Matrix Gla Protein in Ossifying Long Bones In Vitro
OP-1 (BMP-7) 影响体外长骨骨化中 I、II、X 型胶原和基质 Gla 蛋白的 mRNA 表达
- DOI:
- 发表时间:
1997 - 期刊:
- 影响因子:6.2
- 作者:
A. Haaijman;Rena N. D'Souza;A. Bronckers;S. Goei;E. H. Burger - 通讯作者:
E. H. Burger
Rena N. D'Souza的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rena N. D'Souza', 18)}}的其他基金
Self-assembling Peptide Nanofiber Hydrogels for Delivery of Proteins and Cells
用于输送蛋白质和细胞的自组装肽纳米纤维水凝胶
- 批准号:
8237780 - 财政年份:2011
- 资助金额:
$ 36.06万 - 项目类别:
Self-assembling Peptide Nanofiber Hydrogels for Delivery of Proteins and Cells
用于输送蛋白质和细胞的自组装肽纳米纤维水凝胶
- 批准号:
8776683 - 财政年份:2011
- 资助金额:
$ 36.06万 - 项目类别:
Self-assembling Peptide Nanofiber Hydrogels for Delivery of Proteins and Cells
用于输送蛋白质和细胞的自组装肽纳米纤维水凝胶
- 批准号:
8385524 - 财政年份:2011
- 资助金额:
$ 36.06万 - 项目类别:
Self-assembling Peptide Nanofiber Hydrogels for Delivery of Proteins and Cells
用于输送蛋白质和细胞的自组装肽纳米纤维水凝胶
- 批准号:
8578076 - 财政年份:2011
- 资助金额:
$ 36.06万 - 项目类别:
Self-assembling Peptide Nanofiber Hydrogels for Delivery of Proteins and Cells
用于输送蛋白质和细胞的自组装肽纳米纤维水凝胶
- 批准号:
8962150 - 财政年份:2011
- 资助金额:
$ 36.06万 - 项目类别:
Regulation of Runx2 Function by Twist-1 in Tooth Development
Twist-1 在牙齿发育中对 Runx2 功能的调节
- 批准号:
7837315 - 财政年份:2009
- 资助金额:
$ 36.06万 - 项目类别:
相似国自然基金
β2AR激动剂与微秒电刺激对大鼠肛提肌线粒体有氧代谢酶及其多模态影像表型的影响研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
环境激素壬基酚对变应性鼻炎的影响及其对GPER特异性激动剂G-1在变应性鼻炎治疗作用中的干扰机制研究
- 批准号:82000963
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
促生长激素释放激素激动剂抑制平滑肌细胞转分化对动脉粥样硬化的影响及机制研究
- 批准号:81900389
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
五羟色胺2C受体激动剂对2型糖尿病小鼠β细胞功能的影响及机制研究
- 批准号:81803644
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
cAMP信号激动剂对恶性胶质瘤血管新生和血管正常化的影响及机制研究
- 批准号:81803568
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Optogenetic and chemogenetic regulation of uterine vascular function
子宫血管功能的光遗传学和化学遗传学调控
- 批准号:
10785667 - 财政年份:2023
- 资助金额:
$ 36.06万 - 项目类别:
Targeting T2 inflammation-evoked mechanical endotypes of ASM shortening in asthma
靶向哮喘中 ASM 缩短的 T2 炎症诱发机械内型
- 批准号:
10657988 - 财政年份:2023
- 资助金额:
$ 36.06万 - 项目类别:
Multifunctional Nanoparticle Platform to Prevent Alcohol-Associated HCC Development
多功能纳米颗粒平台可预防酒精相关的 HCC 发展
- 批准号:
10736984 - 财政年份:2023
- 资助金额:
$ 36.06万 - 项目类别:
Cannabis and Pathogenic Mechanisms influencing Blood Brain Barrier Function in HIV
大麻和影响艾滋病毒血脑屏障功能的致病机制
- 批准号:
10683027 - 财政年份:2023
- 资助金额:
$ 36.06万 - 项目类别:
Neural and Renal Contributions to Hypertension with Androgen Deprivation Therapy
雄激素剥夺疗法对高血压的神经和肾脏影响
- 批准号:
10662133 - 财政年份:2023
- 资助金额:
$ 36.06万 - 项目类别: